SEPHIENCE DIN 02561824
Health Canada record
| Active ingredient(s) | SEPIAPTERIN 250 MG |
|---|---|
| Dosage form | Powder |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A16AX28 SEPIAPTERIN |
| Original market date | 01-Dec-2025 |
| Current status date | 01-Dec-2025 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SEPIAPTERIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02561832 | SEPHIENCE | PTC THERAPEUTICS INTERNATIONAL LIMITED | Powder | SEPIAPTERIN 1000 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36125 | 2025-10-07 | New Drug Submission (NDS) |